248 related articles for article (PubMed ID: 26950735)
1. Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.
Crane CH; Koay EJ
Cancer; 2016 Jul; 122(13):1974-86. PubMed ID: 26950735
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer.
Crane CH
J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i53-i57. PubMed ID: 27029741
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Gkika E; Hallauer L; Kirste S; Adebahr S; Bartl N; Neeff HP; Fritsch R; Brass V; Nestle U; Grosu AL; Brunner TB
BMC Cancer; 2017 Nov; 17(1):781. PubMed ID: 29162055
[TBL] [Abstract][Full Text] [Related]
4. [Stereotactic extracranial radiosurgery of liver tumors using respiratory gating--the method presentation].
Miszczyk L; Majewski W; Matuszewski M; Kulik R; Kowalski A; Pozniak-Balicka R
Przegl Lek; 2007; 64(7-8):454-61. PubMed ID: 18409344
[TBL] [Abstract][Full Text] [Related]
5. Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
Sanuki N; Takeda A; Mizuno T; Oku Y; Eriguchi T; Iwabuchi S; Kunieda E
AJR Am J Roentgenol; 2013 Dec; 201(6):W812-20. PubMed ID: 24261388
[TBL] [Abstract][Full Text] [Related]
6. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
[TBL] [Abstract][Full Text] [Related]
7. Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.
Gkika E; Schultheiss M; Bettinger D; Maruschke L; Neeff HP; Schulenburg M; Adebahr S; Kirste S; Nestle U; Thimme R; Grosu AL; Brunner TB
Radiat Oncol; 2017 Jul; 12(1):116. PubMed ID: 28701219
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors.
Barney BM; Olivier KR; Macdonald OK; Fong de Los Santos LE; Miller RC; Haddock MG
Am J Clin Oncol; 2012 Dec; 35(6):537-42. PubMed ID: 21659830
[TBL] [Abstract][Full Text] [Related]
9. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
[TBL] [Abstract][Full Text] [Related]
10. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.
Van De Voorde L; Vanneste B; Houben R; Damen P; van den Bogaard J; Lammering G; Dejong K; de Vos-Geelen J; Buijsen J; Öllers M; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Feb; 41(2):249-56. PubMed ID: 25468743
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
Doi H; Beppu N; Kitajima K; Kuribayashi K
Anticancer Res; 2018 Feb; 38(2):591-599. PubMed ID: 29374681
[TBL] [Abstract][Full Text] [Related]
12. Ablative Radiotherapy Doses for Locally Advanced: Pancreatic Cancer (LAPC).
Crane CH; O'Reilly EM
Cancer J; 2017; 23(6):350-354. PubMed ID: 29189331
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors.
Kirichenko A; Gayou O; Parda D; Kudithipudi V; Tom K; Khan A; Abrams P; Szramowski M; Oliva J; Monga D; Raj M; Thai N
HPB (Oxford); 2016 Jan; 18(1):88-97. PubMed ID: 26776856
[TBL] [Abstract][Full Text] [Related]
15. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
[TBL] [Abstract][Full Text] [Related]
17. Accumulated Delivered Dose Response of Stereotactic Body Radiation Therapy for Liver Metastases.
Swaminath A; Massey C; Brierley JD; Dinniwell R; Wong R; Kim JJ; Velec M; Brock KK; Dawson LA
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):639-48. PubMed ID: 26461006
[TBL] [Abstract][Full Text] [Related]
18. Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience.
Wurm RE; Gum F; Erbel S; Schlenger L; Scheffler D; Agaoglu D; Schild R; Gebauer B; Rogalla P; Plotkin M; Ocran K; Budach V
Acta Oncol; 2006; 45(7):881-9. PubMed ID: 16982554
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.
O'Connor JK; Trotter J; Davis GL; Dempster J; Klintmalm GB; Goldstein RM
Liver Transpl; 2012 Aug; 18(8):949-54. PubMed ID: 22467602
[TBL] [Abstract][Full Text] [Related]
20. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]